Reckitt Benckiser Group PLC Investors: Please contact the Portnoy Law Firm to recover your losses. August 4, 2025 Deadline to file Lead Plaintiff Motion

Core Viewpoint - A class action lawsuit has been filed against Reckitt Benckiser Group PLC, alleging that the company made misleading statements regarding the health risks associated with its Enfamil infant formula, particularly for preterm infants [3][4]. Group 1: Class Action Details - The class action represents investors who purchased Reckitt Benckiser securities between January 13, 2021, and July 28, 2024, with a deadline for filing a lead plaintiff motion set for August 4, 2025 [1]. - The lawsuit claims that Reckitt Benckiser failed to disclose the increased risk of Necrotizing Enterocolitis (NEC) for preterm infants consuming its cow's milk-based formula [3]. Group 2: Legal Allegations and Impact - A jury found Mead Johnson, a subsidiary of Reckitt Benckiser, negligent in a case related to NEC, resulting in a $60 million verdict on March 15, 2024, which led to a nearly 14% drop in Reckitt Benckiser's American Depositary Shares (ADSs) [4]. - Following a related case that awarded $495 million in damages for NEC caused by a competing formula, Reckitt Benckiser's ADSs fell nearly 9% on July 29, 2024 [5]. Group 3: Company Background - Reckitt Benckiser is a U.K.-based global consumer goods company that acquired Mead Johnson Nutrition for $19.7 billion in 2017 [2].